Synthesis of Trimegestone: The First Industrial Application of Bakers' Yeast Mediated Reduction of a Ketone
详细信息    查看全文
文摘
Trimegestone(17-methyl-17-(2(S)-hydroxy-1-oxopropyl)estra-4,9-dien-3-one) is a new progestomimetic moleculedeveloped by Roussel Uclaf for the treatment ofpostmenopausaldiseases. It is produced on an industrial scale from arelated3-ketal, 17-keto norsteroid intermediate in a nine-stepsequenceinvolving hydrocyanation of the 17-keto group, alkylationofthe protected cyanohydrin with ethyl magnesium bromide togive a 17-hydroxy 20-ketone, stereospecific17-methylationof the corresponding 17,20-enolate, and oxidation of the20,21-enolate with air and ketal deprotection to give3,20,21-triketone. The key step of the synthesis is the chemo-,regio-,and almost stereospecific bioreduction of this triketone tothedesired 21(S) alcohol, Trimegestone (de = 99%).This bioreduction is performed with bakers' yeast in water, thusshowingthe efficiency of this method at an industrial level.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700